We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Edan Instruments

EDAN Instruments manufactures and distributes diagnostic medical equipments in the areas of obstetrics & gynecology, ... read more Featured Products: More products

Download Mobile App





Edan Debuts Next-Gen Blood Gas & Chemistry Analyzer and Patient Monitor at MEDICA 2021

By LabMedica International staff writers
Posted on 17 Nov 2021
Print article
Image: EDAN at MEDICA 2021 (Photo courtesy of EDAN Instruments, Inc.)
Image: EDAN at MEDICA 2021 (Photo courtesy of EDAN Instruments, Inc.)

EDAN Instruments, Inc. (Shenzhen, China) introduced five new products that are aimed at improving caregiver efficacy and resource accessibility at MEDICA 2021.

Three ready-to-launch products from EDAN, namely its next-gen blood gas and chemistry analysis system i20, 3rd Generation patient monitor iX Series, and the integrated portable version biofeedback and stimulation system PA4 Pro made their debut at MEDICA 2021. EDAN also highlighted its recently-introduced paperless tablet ECG machine iSE and 5-part auto hematology analyzer H60s.

EDAN’s iSE series 12/18 lead ECG machine features an outstanding tablet design and is intended to bring exceptional mobile experience and build a seamless connection to IT systems. It is suitable for applications such as ambulance or first-aid, as well as modern paperless informationized hospitals. Weighing less than one kg, it can start sampling automatically once all lead cables are connected and the desired signal quality is achieved. Its innovative self-adaptive AC filter technology ensures more desirable ECG signal quality in real clinical settings, especially under extreme environments with unstable voltage.

"The products we present this time is mind-changing," said EDAN's Senior Director of Global Marketing and Strategic Operations, Alex You. "In healthcare, efficacy speaks volumes about how technologies make a positive impact on paramedics' workflow, and further save time for patient interaction and more. On iSE, you can have a glance at our plan in IoMT. Intelligent healthcare and IoT-enabled devices have been our focus in recent years. We believe med-tech can improve patient care, and IoT can make this one step further."

"EDAN remains committed to improving people's lives by providing value-driven, user-centered products. The needs are continually evolving. And that's our job to adapt to it and continually optimize our products for the market," added Hao Zhang, CEO of EDAN. "Our mission is to make caregivers' work easier so that they could do more for patients. And the product we present this time just speaks for it."

Related Links:
EDAN Instruments, Inc. 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.